DO, Elizabeth K., Albert KŠIŇAN, Sunny J KIM, Egidio G. DEL FABBRO and Bernard F. FUEMMELER. Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample. Cancer. HOBOKEN: WILEY, 2021, 10 pp. ISSN 0008-543X. Available from: https://dx.doi.org/10.1002/cncr.33794.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Cannabis use among cancer survivors in the United States: Analysis of a nationally representative sample
Authors DO, Elizabeth K., Albert KŠIŇAN, Sunny J KIM, Egidio G. DEL FABBRO and Bernard F. FUEMMELER.
Edition Cancer, HOBOKEN, WILEY, 2021, 0008-543X.
Other information
Original language English
Type of outcome Article in a journal
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 6.921
Doi http://dx.doi.org/10.1002/cncr.33794
UT WoS 000674914100001
Keywords in English cancer; cannabis; Population Assessment of Tobacco and Health (PATH)
Tags International impact, Reviewed
Changed by Changed by: Mgr. Albert Kšiňan, Ph.D., učo 206577. Changed: 9/9/2021 10:12.
Abstract
Background Research on cannabis use among those with a history of cancer is limited. Methods Prevalence of past-year cannabis use among individuals with and without a cancer history and predictors of use within these 2 groups were determined using data from the Population Assessment of Tobacco and Health study, a nationally representative, longitudinal survey conducted in the United States (waves 1-4; 2013-2018). Discrete time survival analyses were used to estimate baseline (wave 1) predictors (physical health status, mental health status, pain, and demographic variables) on past-year engagement with cannabis within individuals who reported a cancer diagnosis at wave 1 (n = 1022) and individuals who reported never having cancer at any wave (n = 19,702). Results At the most recent survey, 8% of cancer survivors reported past-year cannabis use, compared with 15% of those without a cancer history. Across 4 time points, an estimated 3.8% of cancer survivors engaged with cannabis, as compared to 6.5% of those without a cancer history. Across both groups, older age and having health insurance were associated with lower likelihood of engaging in cannabis use, whereas greater levels of pain were associated with higher likelihood of engaging in cannabis use. Among those without a cancer history, being female, White, and having better mental health status were associated with lower likelihood of engaging in cannabis use. Conclusions Although cannabis use prevalence is lower among cancer survivors, the reasons for use are not markedly different from those without a cancer history. Continued monitoring of use, reasons for use, and harms or benefits is warranted. Lay Summary Results from this study, which uses data from the Population Assessment of Tobacco and Health Study, indicate that cannabis use is generally increasing across cancer survivors and those without a history of cancer. Cancer survivors are using cannabis at slightly lower rates than those without a history of cancer. Factors related to pain seem to be more prevalent in cancer populations relative to the general population, and could be contributing to cannabis use within cancer survivor populations.
PrintDisplayed: 18/7/2024 23:21